BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Career Advice

  What to Do if You Think You’re About to Get Fired

  Perhaps you sense something just isn’t quite right, but you’re not sure what. Or, maybe you have a pretty good idea that your organization is slimming down and your role will be one of the first ones to go.

  February 14, 2019

   · 

  2 min read

   · 

  Editorial Staff
• 

  Business

  AstraZeneca Announces Pipeline Cuts, MedImmune Restructuring in 2018 Earnings

  Investors are showing some love to AstraZeneca on this Valentine’s Day after the company posted strong year-end results. Shares of AstraZeneca are up more than 6 percent in premarket trading on the strength of the company’s financial results.

  February 14, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Novartis’ Busy Day: 10-Target Deal With AbCellera and FDA Approves Parasite Drug

  Novartis announced that the FDA approved the company’s Egaten to treat fascioliasis in patients six years of age and older. Novartis also inked a multi-target and multi-year collaboration with AbCellera.

  February 14, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Cambridge’s Cadent Therapeutics Taps Industry Vet as New CEO

  There is a new chief executive officer guiding Cambridge, Mass.-based Cadent Therapeutics. This morning, the company announced long-time industry veteran Jodie Morrison will take over the reins of the company.

  February 14, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics

  Israel-based Teva Pharmaceutical is the largest generic drug company in the world. One in 10 drugs taken in the U.S. are manufactured by Teva, but as generic drug prices are forced downward, the company has struggled.

  February 14, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Merck Eyes Plans Phase III Programs in Prostate Cancer With Keytruda

  The pharma giant announced plans to expand its immuno-oncology program with three new Phase III trials following promising data from a combination of Keytruda and Lynparza and other agents.

  February 14, 2019

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  February 15 Research Roundup: Rare Pediatric Cancer, Hibernating Hamsters, Prostate Cancer and More

  There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

  February 14, 2019

   · 

  6 min read

   · 

  Mark Terry
• Fujitsu Launches “Healthcare Personal service Platform” to Manage Health and Medical Information

  Strongly supporting companies and regional authorities that seek to provide new services for healthy, more fulfilling lifestyles

  February 14, 2019

   · 

  6 min read
• Business

  MDxHealth (R): MDxHealth Signs Partnership with LifeLabs to Make SelectMDx available in Canada

  MDxHealth SA announces that it has signed an exclusive distribution agreement with LifeLabs to make SelectMDx®, the Company’s non-invasive liquid biopsy prostate cancer test, available in Canada.

  February 14, 2019

   · 

  5 min read
• Business

  Karolinska Development: Q4 and 2018 Year-End Report - January-December

  Karolinska Development AB publishes its Q4 and 2018 Year-End Report with a positive quarterly and full-year result. The full report is available on the Company’s website.

  February 14, 2019

   · 

  8 min read